UTI Asset Management Company Q2 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹10,599 Cr
- P/E
- 19.86
- ROE
- 10.33%
- PEG
- 8.19
- Price to sales
- 5.55
- Debt to equity
- 0.03
- 52W high / low
- ₹1,277 / ₹807
- Sales growth (5Y)
- 7.84%
- EBITDA margin
- 44.52%
- Net profit margin
- 32.24%
- Sales (last year)
- ₹1,909 Cr
UTI Asset Management Company Ltd is primarily engaged in the activities of raising funds for and to render investment management services to schemes of UTI Mutual Fund. It is registered with SEBI under the SEBI (Mutual Funds) Regulations, 1996.[1] It was the first to introduce Mutual Funds in India and is focused solely on Investment management and related services.[2]
Guidance scorecard · Q2 FY27 call
What UTI AMC's management guided
and where it ranks in Capital Markets
Capital Markets
RevenueQ1 FY27 call
0–10%- UTI AMC targets to manage 2x current AUM by 2031, with current staffing and technology investments supporting this growth.
- Q1 FY27 showed strong momentum with quarterly average AUM nearing Rs 4,00,000 crores, a 12.6% YoY industry growth.
- Robust product pipeline includes passive products like UTI Nifty 500 ETF and new active offerings (balanced hybrid, sectoral debt funds).
- Plans to launch SIF and GIFT City outbound funds in H2 FY27 to tap new growth areas.
- Emphasis on expanding SIP franchise and investor reach, adding 3.89 lakh folios and 2.51 lakh new investors in Q1.
- Improved digital capabilities driving 23.93% YoY growth in digital purchase transactions.
2 more points from UTI AMC's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
FlatSee what UTI AMC said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- UTI AMC is expanding both passive and active investment offerings with new product launches, including UTI Nifty 500 ETF, UTI BSE Index Sector Leaders ETF, balanced hybrid funds, sectoral debt funds, and GIFT City outbound funds planned in H2 FY27.
- The company completed major IT and digital initiatives (digital asset revamp, cloud infrastructure, Salesforce automation, data lake) with no significant additional capital expense expected this financial year; modest 8%-10% increase in IT/digital spend…
- Strategic investments include doubling headcount in UTI Pension Fund over the next 18 months to support private pension business growth.
2 more points from UTI AMC's call on capex
Create a free account to keep reading this call
FundraisingQ1 FY27 call
See what UTI AMC said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
- Financial performance and growth outlook
- Market share and AUM growth strategies
- Investment performance and product pipeline
- Employee count and cost management
- Buyback considerations and M&A optionality
2 more points from UTI AMC's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Capital Markets
on management's own guidance
- Nippon Life Ind.Good growth2
- BSEGood growth1
- Motil.Oswal.Fin.Good growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Capital Markets companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | BSE | 20–40% | Flat | ₹1.37L Cr | 48.4 |
| 2 | Nippon Life Ind. | 20–40% | Flat | ₹68,184 Cr | 41.6 |
| 3 | Motil.Oswal.Fin. | 20–40% | Flat | ₹63,771 Cr | 32.2 |
| 4 | 20–40% | Flat | ₹31,481 Cr | 29.1 | |
| 5 | 20–40% | Flat | ₹15,334 Cr | 43.8 | |
| 6 | 20–40% | Flat | ₹12,638 Cr | 51.6 |
Sign up free to see every company in the sector ranking and track UTI AMC.
Pro shows every company guiding 40%+ revenue growth →Full Capital Markets rankingFinancials of UTI AMC
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Shareholder Pattern
UTI AMC
Shareholding breakup across reporting periods.
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FIIs + | 5.57% | 5.97% | 6.27% | 7.20% | 7.85% | 7.85% | 7.70% | 7.62% | 7.27% | 7.11% | 6.89% | 6.71% |
| DIIs + | 61.13% | 60.93% | 60.67% | 60.19% | 59.27% | 59.71% | 59.47% | 59.71% | 60.00% | 60.07% | 59.62% | 59.12% |
| Public + | 33.31% | 33.12% | 33.08% | 32.62% | 32.88% | 32.44% | 32.84% | 32.68% | 32.75% | 32.82% | 33.51% | 34.17% |
| No. of Shareholders | 1,52,127 | 1,48,066 | 1,44,944 | 1,62,837 | 1,80,656 | 1,70,067 | 1,62,002 | 1,61,911 | 1,59,631 | 1,59,484 | 1,64,544 | 1,67,419 |
Financials of UTI AMC
Quarterly Results
Quarter-by-quarter operating performance
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 404 | 449 | 416 | 529 | 538 | 418 | 376 | 547 | 419 | 517 | 390 | 584 | 415 |
| Expenses + | 173 | 176 | 188 | 178 | 190 | 185 | 207 | 207 | 241 | 215 | 402 | 201 | 223 |
| Operating Profit | 232 | 273 | 228 | 351 | 348 | 233 | 169 | 340 | 177 | 302 | -12 | 383 | 191 |
| OPM % | 57% | 61% | 55% | 66% | 65% | 56% | 45% | 62% | 42% | 58% | -3.1% | 66% | 46% |
| Other Income + | 2 | 1 | 4 | 5 | 2 | 3 | 0 | 2 | 3 | -108 | 12 | 2 | 0 |
| Interest | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 10 | 10 | 12 | 11 | 11 | 11 | 12 | 12 | 13 | 13 | 13 | 13 | 13 |
| Profit before tax | 220 | 261 | 218 | 341 | 336 | 221 | 154 | 326 | 164 | 178 | -17 | 368 | 175 |
| Tax % | 17% | 22% | 17% | 20% | 22% | 22% | 34% | 22% | 19% | 23% | 206% | 20% | 24% |
| Net Profit + | 183 | 203 | 181 | 274 | 263 | 174 | 102 | 254 | 132 | 138 | -51 | 294 | 132 |
| EPS in Rs | 14.39 | 14.59 | 12.79 | 19.97 | 18.76 | 11.78 | 6.83 | 18.50 | 8.81 | 9.41 | -5.19 | 22.86 | 10.29 |
Financials of UTI AMC
Profit & Loss
Annual income statement trend
| Mar 2011 | Mar 2012 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 497 | 502 | 934 | 1,134 | 1,051 | 854 | 1,169 | 1,319 | 1,267 | 1,737 | 1,851 | 1,705 | 1,906 |
| Expenses + | 292 | 298 | 499 | 577 | 552 | 506 | 526 | 621 | 655 | 703 | 749 | 889 | 1,041 |
| Operating Profit | 206 | 204 | 435 | 558 | 498 | 349 | 643 | 698 | 612 | 1,034 | 1,102 | 816 | 864 |
| OPM % | 41% | 41% | 47% | 49% | 47% | 41% | 55% | 53% | 48% | 60% | 60% | 48% | 45% |
| Other Income + | 2 | 1 | 13 | 22 | 30 | 36 | 4 | 8 | 23 | 6 | 9 | -100 | -94 |
| Interest | 0 | 0 | 0 | 0 | 8 | 9 | 8 | 9 | 10 | 11 | 13 | 13 | 13 |
| Depreciation | 9 | 10 | 13 | 14 | 29 | 34 | 36 | 37 | 40 | 42 | 46 | 51 | 52 |
| Profit before tax | 199 | 195 | 435 | 566 | 491 | 341 | 603 | 660 | 586 | 987 | 1,052 | 652 | 705 |
| Tax % | 30% | 25% | 26% | 29% | 29% | 19% | 18% | 19% | 25% | 19% | 23% | 28% | |
| Net Profit + | 139 | 147 | 321 | 402 | 348 | 275 | 494 | 535 | 440 | 802 | 813 | 472 | 513 |
| EPS in Rs | 11.12 | 11.73 | 25.29 | 31.68 | 27.83 | 21.41 | 38.97 | 42.09 | 34.44 | 60.17 | 57.16 | 31.44 | 37.37 |
| Dividend Payout % | 25% | 23% | 16% | 16% | 18% | 33% | 44% | 50% | 64% | 78% | 84% | 127% |
Financials of UTI AMC
Balance Sheet
Capital structure and asset base
| Mar 2011 | Mar 2012 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 125 | 125 | 127 | 127 | 127 | 127 | 127 | 127 | 127 | 127 | 128 | 129 | 129 |
| Reserves | 743 | 855 | 1,789 | 2,161 | 2,478 | 2,646 | 3,125 | 3,493 | 3,741 | 4,261 | 4,471 | 4,376 | 4,285 |
| Borrowings + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 142 | 141 | 138 |
| Other Liabilities + | 218 | 202 | 205 | 262 | 409 | 393 | 398 | 363 | 307 | 953 | 917 | 398 | 405 |
| Total Liabilities | 1,086 | 1,182 | 2,121 | 2,550 | 3,013 | 3,165 | 3,650 | 3,983 | 4,175 | 5,341 | 5,658 | 5,043 | 4,956 |
| Fixed Assets + | 208 | 201 | 278 | 273 | 351 | 373 | 360 | 357 | 368 | 412 | 408 | 405 | 396 |
| CWIP | 0 | 0 | 3 | 5 | 1 | 1 | 5 | 8 | 9 | 3 | 11 | 4 | 3 |
| Investments | 646 | 720 | 1,543 | 1,932 | 2,261 | 2,356 | 2,747 | 2,994 | 3,248 | 4,428 | 4,558 | 3,988 | 3,945 |
| Other Assets + | 232 | 260 | 297 | 339 | 400 | 436 | 539 | 623 | 550 | 498 | 681 | 647 | 612 |
| Total Assets | 1,086 | 1,182 | 2,121 | 2,550 | 3,013 | 3,165 | 3,650 | 3,983 | 4,175 | 5,341 | 5,658 | 5,043 | 4,956 |
Financials of UTI AMC
Cash Flows
Operating, investing and financing cash movement
| Mar 2011 | Mar 2012 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 72 | 324 | 316 | 123 | 181 | 153 | 337 | 395 | 325 | 536 | 407 | |
| Cash from Investing Activity + | -22 | -242 | -233 | -26 | -102 | -57 | -60 | -93 | -146 | 124 | -34 | |
| Cash from Financing Activity + | -35 | -65 | -44 | -123 | -84 | -104 | -215 | -267 | -238 | -554 | -594 | |
| Net Cash Flow | 16 | 16 | 39 | -26 | -5 | -8 | 62 | 36 | -59 | 106 | -221 | |
| Free Cash Flow | 70 | 219 | 306 | 116 | 136 | 126 | 299 | 344 | 245 | 486 | 366 | |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 38% | 77% | 59% | 58% | 76% | 35% | 67% | 88% | 48% | 69% | 77% |
Financials of UTI AMC
Ratios
Working capital efficiency and return ratios
| Mar 2011 | Mar 2012 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 5 | 18 | 3 | 9 | 10 | 19 | 14 | 22 | 27 | 18 | 16 | 17 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 5 | 18 | 3 | 9 | 10 | 19 | 14 | 22 | 27 | 18 | 16 | 17 |
| Working Capital Days | -62 | -44 | -28 | -40 | -31 | -24 | -47 | -31 | -32 | -33 | -23 | -31 |
| ROCE % | 21% | 27% | 20% | 13% | 20% | 19% | 16% | 23% | 21% | 16% |
Guidance history
How UTI AMC's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 0–10% | Flat | Planned | — | — |
| Q4 FY26 call → | 10–20% | Flat | None planned | — | — |
| Q2 FY26 call → | 10–20% | Flat | — | — | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
14 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −36.9% | 15% |
| Last 6 months | −13.8% | 31% |
| Last 3 months | −10.1% | 43% |
The price is 42.5% below its all-time high of ₹1,431.6 (18 Jul 2025). Stocks more than 20% below their peak have their score halved, so 27 became 14.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For UTI AMC: 0.4 × 15 + 0.4 × 31 + 0.2 × 43 = 27, halved to 14 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 28 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What UTI AMC's management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q4 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
Others in Capital Markets this season
- CARE Ratings (Q2 FY27)
164.13 Crs, up 20% YoY (Page 2) . Key investor presentation takeaways from CARE Ratings Ltd's Q2 FY27 investor presentation — and how it ranks against sector pe
- Computer Age Management Services Ltd (Q2 FY27)
Q2 FY’27 Revenue from operations: ₹41,446.57 Lakh, up 10.0% YoY (₹37,673.79 Lakh in Q2 FY’26). Key investor presentation takeaways from Computer Age Management
- ICRA (Q2 FY27)
Q2 FY2027 Group Revenue: ₹177.9 crore (up from ₹136.6 crore in Q2 FY2026) – ~30.2% YoY growth . Key investor presentation takeaways from ICRA Ltd's Q2 FY27 inve
- Motilal Oswal Financial Services Ltd (Q2 FY27)
Total Net Revenues for Q2FY27: ₹1,757 crore, up 20% YoY from ₹1,460 crore in Q2FY26 (Page 18). Key investor presentation takeaways from Motilal Oswal Financial
